Business
Palantir Showcases AI Operations Shift at AIPCon 11
Palantir’s AIPCon 11 highlighted real-world AI deployments across defense, pharma, aviation and finance, underscoring CEO Alex Karp’s push for operational rather than theoretical AI.
Adobe Beats Q3 Estimates, but Soft Q4 Outlook Dampens Shares
Adobe posted record Q3 results with $6.76 billion in revenue and $6.13 adjusted EPS, but flagged a revenue midpoint below consensus for Q4, sending shares down 2.7% in premarket trade.
Oracle Raises Profit Outlook After Beating Q1 Earnings on AI Cloud Demand
Oracle posted adjusted EPS of $1.92 vs $1.73 expected, booking more than $30 billion in new AI cloud contracts. The company raised its full-year profit forecast amid strong demand.
LUKB Names Stefan Studer as New CEO,Replacing Daniel Salzmann
Stefan Studer takes over Luzerner Kantonalbank helm Jan. 1, 2027, succeeding outgoing CEO Daniel Salzmann; both join supervisory board amid leadership reshuffle.
AI reshapes entry-level hiring as grunt work disappears
Companies including ad agencies and banks are redesigning early-career roles as AI takes over tasks once handed to juniors, raising concerns about skills development.
STARTRADER’s STARCares Supports SOS Children’s Village in Ho Chi Minh City
The broker’s CSR arm delivered gift sets, household supplies and cash aid to the SOS Children’s Village in Ho Chi Minh City, benefitting 213 residents including 60 children during a Mid‑Autumn Festival event.
Lyell Finishes LYL273 Manufacturing Transfer, Plans 2027 FDA Meeting
Lyell Immunopharma completes technology transfer of its CAR T-cell candidate to Bothell facility; Phase 1/2 CARABiNER trial data expected in 2027.
NewAmsterdam Pharma's Obicetrapib Nears Key Trial Data as Stock Slips
Shares of the cardiovascular drug developer fell 2.85% as management detailed obicetrapib's clinical momentum, including LDL-lowering efficacy and trial timelines, ahead of pivotal PREVAIL results due by year-end.
Scott Bessent Named as Potential Trump KI Advisor
U.S. Treasury Secretary Scott Bessent could become Donald Trump’s new artificial intelligence advisor, according to an insider report.
UK aims to lead global AI regulation, says PM Burnham at UN
British Prime Minister Andy Burnham told the UN General Assembly that the UK will push for internationally agreed AI rules, citing security risks and a new information‑defence centre.
Trisura hits CAD 1B book value ahead of schedule at Scotiabank summit
Canadian specialty insurer reaches capital milestone 18 months early, outlines U.S. expansion and growth targets across surety, corporate insurance and programs lines.
Axsome Therapeutics Highlights Auvelity Growth and Pipeline Progress at Cantor Conference
The biotech reported second‑quarter 2026 Auvelity revenue of $180 million, outlined an annualized run rate of $720 million and detailed advances in its depression, Alzheimer’s agitation and neuropsychiatric pipeline.
ADI Global Distribution Targets $80M in Savings as Tariff Benefits Reverse
The commercial security distributor raised its full-year margin outlook on tariff-related pricing gains but warned of an 80 basis-point headwind next year as benefits unwind.
TE Connectivity Says Growth Broadening Beyond AI at Jefferies Conference
CEO Terrence Curtin says AI accounts for roughly 40% of projected $2.5B growth this year as data-center, automotive, and energy segments post strength.
Ørsted Gets Tax Win on UK Wind Farms
Danish energy firm secured a favorable EU arbitration ruling confirming UK taxing rights over its Walney Extension and Hornsea 1 projects.
Box Ties Content Management to ChatGPT for Enterprise Access
Box integrates its document platform with ChatGPT, letting users browse, search and edit files inside OpenAI's chatbot while maintaining existing permissions and security controls.
Putin Places Nestle's Russian Assets Under Temporary Administration
Nestle shares fell 2.2% as Russia put its Russian business under state-appointed administrators, part of a widening campaign against Western companies still operating in the country.
ETFs Remain Supplementary, Not Core, in Swiss Retail Portfolios
A Lucerne University study finds most Swiss ETF investors still allocate under half their portfolios to the products, even as demand surges.
UroGen Says Zusduri Launch Accelerates as H1 Revenue Hits $50 Million
UroGen reported sequential revenue growth for Zusduri and submitted an NDA for its next-generation bladder cancer drug, while asserting its cash runway can carry it to profitability.
AT&T convergence strategy gains ground after Q2 service revenue beat
AT&T reaffirmed its full-year outlook and shareholder return plans at a Bank of America conference, highlighting accelerating convergence metrics and a $45 billion buyback/dividend commitment.
Arvinas Highlights Pipeline at Cantor Fitzgerald Healthcare Conference
Arvinas discusses its clinical pipeline and strategic partnerships at the 12th Annual Cantor Fitzgerald Global Healthcare Conference, emphasizing its focus on degrader programs and commercialization efforts.
Eikon Therapeutics Highlights Cancer Drug Pipeline, Platform Data at Cantor Conference
Biotech firm with $531.2 million cash describes its high-throughput screening platform and updates on TLR7/8 agonist and PARP inhibitor programs ahead of ESMO presentations.
Vertex outlines pipeline momentum, $500M combined CASGEVY-JOURNAVX revenue target
Vertex Pharmaceuticals raised its commercial trajectory at the Cantor Fitzgerald healthcare conference, projecting $5B peak sales from Crinetics assets and more than triple JOURNAVX script growth next year.
Definity Financial lifts growth after Travelers Canada integration
Definity Financial said the CAD 3.3 billion Travelers Canada deal boosted its market rank to No. 4 in Canada’s P&C sector and drove 35% first‑half revenue growth, while keeping full‑year revenue near CAD 6.5 billion.
Maze Therapeutics Presents HORIZON, CIPheR Data at Citi Biopharma Summit
Shares of MAZE rose after CFO Misbah Tahir highlighted Phase II kidney-disease and PKU update data at Citigroup's Biopharma Back to School Summit.